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Dr Munir Boodhwani (Brussels, Belgium). Can you comment
on your power and sample size calculations? It is a smallish study
with negative results. What were your assumptions?
Dr Singh. In our original protocol and proposal for funding, we
hypothesized and calculated that roughly 200 patients would be
required per arm. This would achieve a power of 80%, given an300 The Journal of Thoracic and Cardiovascular Surgassumed event rate in the control group of 9% of grafts occluded,
with a relative risk reduction of 60%. Although we did not actually
recruit our intended sample, the event rate, occlusions in the control
group, was significantly higher at 30%. As well, the relative risk
reduction confidence interval included that which we had hypoth-
esized. On the basis of these parameters, it is reasonable to assume
a reasonable power and to make a meaningful conclusion from this
study.
Dr Boodhwani.Was the harvesting technique for the saphenous
vein similar in both groups?
Dr Singh. The method was standardized in both groups; it was
the conventional, open, nonminimally invasive harvesting tech-
nique.
Dr Jennifer Sue Lawton (St. Louis, Mo). You should be
commended on your low rate of graft revision despite imaging.
In St Louis, we do not have our hybrid operating room ready yet,
so the only thing I can really use for off-pump CABG is the flow
probe. It looked like part of your imaging was flow probe assess-
ment. Do you have any data to correlate your imaging with flow
probe information? In other words, would flow probe data alone
have prompted you to revise your grafts without the angiography
data?
Dr Singh. That is an excellent question. We used both tech-
niques in collaboration, because the evidence from our institution
has shown that the flow probe is more sensitive to complete occlu-
sions and the ICG technique was more sensitive to nonocclusive
disease.
When we looked at the grafts that were not revised, at 1-year
follow-up angiography, we looked at the mean pulsatility indexes,
the mean diastolic flow fractions, and the mean flows. Actually,
there was no difference in those that ultimately were occluded
and those that were not. However, most grafts that were revised
had more findings on the TTF than on the ICG. Thus there was
more of a predilection for revision with positive TTF findings.
Dr Beat H. Walpoth (Geneva, Switzerland). We pioneered the
TTF measurements 15 years ago. I think it is a nice study, but I am
not sure whether you can predict the flow at a 1-year follow-up
based on the initial flow. It would be marvelous, but it is so com-
plex; there are so many factors. However, on the other hand, you
had several revisions during surgery owing to bad flow or bad
visualization of the graft. Therefore, I think you cannot support
your conclusion, because your conclusion says that you should
measure flow only in high-risk patients and sporadically. The point
is, actually, that you should measure all grafts. This takes 1 minute
per graft, and if you measure all grafts you will not miss patients in
whom you should do a revision on site. That is how you will im-
prove your patency in the long run. Could you comment on these
aspects?
Dr Singh.What we have gleaned from our study is that there is
a need for improving quality assurance and that intraoperative tools
can identify potential errors and poorly constructed grafts. How-
ever, we also identified that perhaps there is still a role for clinical
judgment by surgeons as to what grafts are critical and at high risk
for failure, requiring revision, or what grafts should not be revised if
the outcome would be poorer patency owing to technical challenge,
but may not dramatically influence outcomes. As such, the collab-
oration of clinical judgment with objective evidence from intrao-
perative tools probably is what best leads to improving patencyery c February 2010
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Dand avoiding inappropriate graft revisions. As we have seen,
although it is hard to make a meaningful conclusion from a smaller
number, some of the grafts that met revision criteria, but were not
revised because of attending surgeon judgment, were still patent at
1-year follow-up angiography. I think we should not go full force to
say we should use it routinely; however, targeted use of clinical
judgment would probably be most ideal.
DrWalpoth. One follow-up question: If you had only one tech-
nique, which one would you prefer?
Dr Singh. Evidence from our institution, comparing ICG to TTF
to the gold standard, x-ray angiography, has shown that the sensi-
tivity and specificity of ICG for 50% to 90% stenoses and 100%
stenoses is superior to that of TTF. TTF has a sensitivity and spec-
ificity for nonocclusive disease much poorer than that of ICG. Thus
ICG might provide more data. Besides that, it is much more user
friendly and better provides an image that attending surgeons can
easily interpret as opposed to just interpreting numbers that are
provided by TTF.
Dr Keith Horvath (Bethesda, Md). This was an excellent
presentation of a difficult study to conduct. Some might assume
a conclusion from this trial is that hybrid operating rooms are not
really needed, because you have done a nice job showing that
imaging really did not have a significant impact at the time of
surgery. I am wondering whether that is a fair conclusion. My
second question is this: You have demonstrated that there are
many factors responsible for graft failure and that the technicalThe Journal of Thoracic and Caaspects at the time of the grafting, although they play a role, are
probably not as high of a factor in causing graft failure as we think.
From what you have been able to see in the grafts that failed, was
there any either qualitative or semiquantitative assessment of the
distal vessel that may have been the reason for those failures?
Did you learn anything in that regard? The extent of target vessel
disease is probably still a much more important factor in graft fail-
ure than the technical aspects of the operation.
Dr Singh. Thank you for those two questions. Your first ques-
tion concerned the role of imaging and queried the involvement
of evolution of hybrid operating rooms. I think there still is a role
for imaging, especially in the evolution of hybrid operating suites,
because in many situations what is being done is minimal access,
lower exposure, beating heart procedures. As such, these are the pa-
tients that are probably at high risk for poorer construction of distal
anastomoses and, as such, intraoperative angiography or imaging
should have a role.
With respect to your second question, we did note that the graft
revision rate was quite low and that the occlusions at 1 year obvi-
ously are multifactorial. Many things contribute to this, including
distal target characteristics. We have not looked at it in the present
study, but we will be looking at the data and comparing them. One
would anticipate that the degree of distal disease and the native
vessel characteristics, as has been shown in the literature, would
play a role in 1-year patency; however, given the randomization
of the study, we believe the impact should have been balanced.rdiovascular Surgery c Volume 139, Number 2 301
